HLB Pharmaceutical Market Cap

HLB Pharmaceutical has a market cap or net worth of 221.45 billion as of December 5, 2025. Its market cap has decreased by -12.63% in one year.

Market Cap

221.45B

Enterprise Value

211.79B

Revenue

36.10B

Ranking

n/a

PE Ratio

468.52

Stock Price

15,770.00

Market Cap Chart

Since December 21, 2015, HLB Pharmaceutical's market cap has increased from 84.28B to 221.45B, an increase of 162.75%. That is a compound annual growth rate of 10.18%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	221.45B	-34.56%
Dec 30, 2024	338.42B	58.45%
Dec 28, 2023	213.58B	43.49%
Dec 29, 2022	148.85B	-21.48%
Dec 30, 2021	189.57B	-21.05%
Dec 30, 2020	240.12B	219.34%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	75.96T
Celltrion	40.11T
ALTEOGEN	24.41T
ABL Bio	10.51T
SK Biopharmaceuticals	10.49T
Yuhan	8,755.13B
LigaChem Biosciences	6,753.15B
Peptron	6,645.44B

Market Cap Rankings